Will the BEAUTIFUL Study results change our views on heart rate control?
The article describes the results of a randomized, double-blind, placebo-controlled, parallel-group BEAUTIFUL trial. The position of an If inhibitor ivabradine in the current algorithm of antianginal therapy is analyzed
Saved in:
| Main Author: | Yu. M. Lopatin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2008-12-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1731 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Heart rate-lowering antianginal medications: what determines their choice?
by: Yu. M. Lopatin
Published: (1970-01-01) -
Coronary heart disease treatment: old principles and new horizons
by: Yu. A. Vasyuk, et al.
Published: (2007-02-01) -
Antianginal treatment of stable angina: focus on heart rate reduction
by: Yu. M. Lopatin
Published: (1970-01-01) -
Effectiveness of a selective If channel inhibitor ivabradine in patients with stable angina
by: E. V. Kuleshova
Published: (2009-10-01) -
Antianginal effectiveness and tolerability of ivabradine in patients with stable angina: CONTROL-2 Study results
by: Yu. A. Karpov, et al.
Published: (1970-01-01)